EDITORIALS

Postmastectomy Radiation Therapy: Who Needs It?

Ivo A. Olivotto, Pauline T. Truong, and Boon Chua

JCO Nov 1 2004: 4237–4239. First published on Sep 27 2004; 10.1200/JCO.2004.06.974. [Full Text] [PDF]

Toward a Glioblastoma Vaccine: Promise and Potential Pitfalls

Howard A. Fine

JCO Nov 1 2004: 4240–4243. First published on Sep 27 2004; 10.1200/JCO.2004.06.927. [Full Text] [PDF]

Support Groups in Breast Cancer: When a Negative Result Is Positive

Pamela J. Goodwin

JCO Nov 1 2004: 4244–4246. First published on Sep 27 2004; 10.1200/JCO.2004.06.926. [Full Text] [PDF]

ORIGINAL REPORTS
Breast Cancer
	Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials
	Alphonse Taghian, Jong-Hyeon Jeong, Eleftherios Mamounas, Stewart Anderson, John Bryant, Melvin Deutsch, and Norman Wolmark
	JCO Nov 1 2004: 4247–4254. First published on Sep 27 2004; 10.1200/JCO.2004.01.042. [Abstract] [Full Text] [PDF]
	Effect of Cognitive-Existential Group Therapy on Survival in Early-Stage Breast Cancer
	David W. Kissane, Anthony Love, Allison Hatton, Sidney Bloch, Graeme Smith, David M. Clarke, Patricia Miach, Jill Ikin, Nadia Ranieri, and Raymond D. Snyder
	JCO Nov 1 2004: 4255–4260. First published on Sep 27 2004; 10.1200/JCO.2004.12.129. [Abstract] [Full Text] [PDF]
	Quality of Life of Postmenopausal Women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) Adjuvant Breast Cancer Trial
	Lesley Fallowfield, David Cella, Jack Cuzick, Stephen Francis, Gershon Locker, and Anthony Howell
	JCO Nov 1 2004: 4261–4271. [Abstract] [Full Text] [PDF]

Neurooncology
	Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit
	Hans Herbert Steiner, Matteo Mario Bonsanto, Philipp Beckhove, Michael Brysch, Karsten Geletneky, Rezvan Ahmadi, Rebecca Schuele-Freyer, Paul Kremer, Golamreza Ranaie, Dejana Matejic, Harald Bauer, Marika Kiessling, Stefan Kunze, Volker Schirrmacher, and Christel Herold-Mende
	JCO Nov 1 2004: 4272–4281. First published on Sep 27 2004; 10.1200/JCO.2004.09.038. [Abstract] [Full Text] [PDF]
	Phase II Study of Fenretinide (NSC 374551) in Adults With Recurrent Malignant Gliomas: A North American Brain Tumor Consortium Study
	Vinay K. Puduvalli, W.K. Alfred Yung, Kenneth R. Hess, John G. Kuhn, Morris D. Groves, Victor A. Levin, James Zwiebel, Susan M. Chang, Timothy F. Cloughesy, Larry Junck, Patrick Wen, Frank Lieberman, Charles A. Conrad, Mark R. Gilbert, Christina A. Meyers, Vivien Liu, Minesh P. Mehta, M. Kelly Nicholas, and Michael Prados
	JCO Nov 1 2004: 4282–4289. [Abstract] [Full Text] [PDF]

Hematologic Malignancies
	Dose Escalation Studies of Cytarabine, Daunorubicin, and Etoposide With and Without Multidrug Resistance Modulation With PSC-833 in Untreated Adults With Acute Myeloid Leukemia Younger Than 60 Years: Final Induction Results of Cancer and Leukemia Group B Study 9621
	Jonathan E. Kolitz, Stephen L. George, Richard K. Dodge, David D. Hurd, Bayard L. Powell, Steven L. Allen, Enrique Velez-Garcia, Joseph O. Moore, Thomas C. Shea, Eva Hoke, Michael A. Caligiuri, James W. Vardiman, Clara D. Bloomfield, and Richard A. Larson
	JCO Nov 1 2004: 4290–4301. [Abstract] [Full Text] [PDF]
	Incidence and Predictors of Low Chemotherapy Dose-Intensity in Aggressive Non-Hodgkin's Lymphoma: A Nationwide Study
	Gary H. Lyman, David C. Dale, Jonathan Friedberg, Jeffrey Crawford, and Richard I. Fisher
	JCO Nov 1 2004: 4302–4311. First published on Sep 20 2004; 10.1200/JCO.2004.03.213. [Abstract] [Full Text] [PDF]

Clinical Trials
	Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision
	James R. Wright, Timothy J. Whelan, Susan Schiff, Sacha Dubois, Dauna Crooks, Patricia T. Haines, Diane DeRosa, Robin S. Roberts, Amiram Gafni, Kathleen Pritchard, and Mark N. Levine
	JCO Nov 1 2004: 4312–4318. [Abstract] [Full Text] [PDF]

Gastrointestinal Cancer
	Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803
	Olivier Bouché, Jean Luc Raoul, Franck Bonnetain, Marc Giovannini, Pierre Luc Etienne, Gérard Lledo, Dominique Arsène, Jean Francois Paitel, Véronique Guérin-Meyer, Emmanuel Mitry, Bruno Buecher, Marie Christine Kaminsky, Jean François Seitz, Philippe Rougier, Laurent Bedenne, and Chantal Milan
	JCO Nov 1 2004: 4319–4328. [Abstract] [Full Text] [PDF]

Radiation Oncology
	Carboplatin/Paclitaxel or Carboplatin/Vinorelbine Followed by Accelerated Hyperfractionated Conformal Radiation Therapy: Report of a Prospective Phase I Dose Escalation Trial From the Carolina Conformal Therapy Consortium
	Lawrence B. Marks, Jennifer Garst, Mark A. Socinski, Gregory Sibley, A. William Blackstock, James E. Herndon Sumin Zhou, Timothy Shafman, Andrea Tisch, Robert Clough, Xiaoli Yu, Andrew Turrisi, Mitchell Anscher, Jeffrey Crawford, and Julian Rosenman
	JCO Nov 1 2004: 4329–4340. [Abstract] [Full Text] [PDF]

Lung Cancer
	Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial
	Mark A. Socinski, David E. Morris, Jan S. Halle, Dominic T. Moore, Thomas A. Hensing, Steven A. Limentani, Robert Fraser, Maureen Tynan, Andrea Mears, M. Patricia Rivera, Frank C. Detterbeck, and Julian G. Rosenman
	JCO Nov 1 2004: 4341–4350. [Abstract] [Full Text] [PDF]
	Role of Lung Transplantation in the Treatment of Bronchogenic Carcinomas for Patients With End-Stage Pulmonary Disease
	Marc de Perrot, Susan Chernenko, Thomas K. Waddell, Yaron Shargall, Andrew F. Pierre, Michael Hutcheon, and Shaf Keshavjee
	JCO Nov 1 2004: 4351–4356. [Abstract] [Full Text] [PDF]

Diagnostics
	Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for Tumor Staging in Solid Tumors: Comparison With CT and PET
	Gerald Antoch, Nina Saoudi, Hilmar Kuehl, Gerlinde Dahmen, Stefan P. Mueller, Thomas Beyer, Andreas Bockisch, Jörg F. Debatin, and Lutz S. Freudenberg
	JCO Nov 1 2004: 4357–4368. [Abstract] [Full Text] [PDF]

Melanoma
	Effect of Pregnancy on Survival in Women With Cutaneous Malignant Melanoma
	Marko B. Lens, Inger Rosdahl, Anders Ahlbom, Bahman Y. Farahmand, Ingrid Synnerstad, Bernt Boeryd, and Julia A. Newton Bishop
	JCO Nov 1 2004: 4369–4375. [Abstract] [Full Text] [PDF]
	Impact of Ulceration in Stages I to III Cutaneous Melanoma As Staged by the American Joint Committee on Cancer Staging System: An Analysis of the German Central Malignant Melanoma Registry
	Thomas K. Eigentler, Petra G. Buettner, Ulrike Leiter, and Claus Garbe
	JCO Nov 1 2004: 4376–4383. [Abstract] [Full Text] [PDF]

Pediatric Oncology
	Early Deaths and Treatment-Related Mortality in Children Undergoing Therapy for Acute Myeloid Leukemia: Analysis of the Multicenter Clinical Trials AML-BFM 93 and AML-BFM 98
	Ursula Creutzig, Martin Zimmermann, Dirk Reinhardt, Michael Dworzak, Jan Stary, and Thomas Lehrnbecher
	JCO Nov 1 2004: 4384–4393. [Abstract] [Full Text] [PDF]
	Phase I and Pharmacokinetic Study of Thalidomide With Carboplatin in Children With Cancer
	Murali Chintagumpala, Susan M. Blaney, Lisa R. Bomgaars, Aleksander Aleksic, John F. Kuttesch, Renee A. Klenke, and Stacey L. Berg
	JCO Nov 1 2004: 4394–4400. [Abstract] [Full Text] [PDF]

Supportive Care and Quality of Life
	Cancer Consultation Preparation Package: Changing Patients but Not Physicians Is Not Enough
	Phyllis Butow, Rhonda Devine, Michael Boyer, Susan Pendlebury, Michael Jackson, and Martin H.N. Tattersall
	JCO Nov 1 2004: 4401–4409. [Abstract] [Full Text] [PDF]
	Phase II Study of Activated Charcoal to Prevent Irinotecan-Induced Diarrhea
	Michael Michael, MaryAnne Brittain, Jane Nagai, Ronald Feld, David Hedley, Amit Oza, Lillian Siu, and Malcolm J. Moore
	JCO Nov 1 2004: 4410–4417. [Abstract] [Full Text] [PDF]

REVIEW ARTICLE
	Efficacy of Coenzyme Q10 for Improved Tolerability of Cancer Treatments: A Systematic Review
	Liz Roffe, Katja Schmidt, and Edzard Ernst
	JCO Nov 1 2004: 4418–4424. [Abstract] [Full Text] [PDF]

ART OF ONCOLOGY

Fellow Suffering

Jennifer Armstrong

JCO Nov 1 2004: 4425–4427. [Full Text] [PDF]

SPECIAL DEPARTMENTS

Correspondence

Iron Supplement in Cancer Patients Receiving Erythropoietin

Paolo Pedrazzoli, Cinzia Tullio, Giulio Cerea, and Salvatore Siena

JCO Nov 1 2004: 4428. [Full Text] [PDF]

In Reply:

Michael Auerbach, Harold Ballard, and Marilyn McIlwain

JCO Nov 1 2004: 4428-a–4429. [Full Text] [PDF]

Myeloid Growth Factors Should Not Be Administered Routinely After Allogeneic Hematopoietic Stem-Cell Transplantation

Jayesh Mehta

JCO Nov 1 2004: 4429–4430. [Full Text] [PDF]

In Reply:

Olle Ringdén

JCO Nov 1 2004: 4430–4432. [Full Text] [PDF]

Delayed-Type Hypersensitivity Reaction With Iscador M Given in Combination With Cytotoxic Chemotherapy

Heather S. Shaw, Katherine B. Hobbs, Victoria L. Seewaldt, and David J. Kroll

JCO Nov 1 2004: 4432–4434. [Full Text] [PDF]

Errata

ERRATUM

JCO Nov 1 2004: 4435. [Full Text] [PDF]

ERRATUM

JCO Nov 1 2004: 4435-a. [Full Text] [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.